Search

everythinglearnresearchcommunity

for

Search:↓

Periplaneta americana extract promotes hair growth and is safe for treating hair loss.

Personalized acne treatments and new therapies show promise for better results.

Anabolic androgenic steroids can increase cancer risk and disrupt hormones.

Metabolic Syndrome is linked to several skin conditions, and stem cell therapy might help treat them.

WNT10B is important for body functions and linked to diseases like osteoporosis, obesity, and cancer.

PCOS involves high 11-oxygenated androgens and BPA may worsen it, while IH is not inflammatory.

Understanding how acne develops in different diseases could lead to new treatments.

Microneedles in wearables can deliver drugs over time but face challenges in manufacturing and safety.

Metal nanoparticles show promise for treating hair loss but need more research to ensure safety.

Polycystic ovary syndrome causes high male hormone levels, leading to symptoms like excess hair, acne, and fertility problems.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

High triglyceride levels are a key factor affecting testosterone levels in women with PCOS.

Hair steroid profiling is a feasible, non-invasive alternative to serum analysis for assessing hormone levels and metabolism.

The guideline emphasizes a multidisciplinary approach and informed consent for gender-affirming hormone treatment, with regular follow-ups and individualized care.

m6A deregulation plays a key role in PCOS and could lead to new treatments.

The seed extract of Lepidium sativum L. can potentially treat hair loss, showing effects similar to 5% minoxidil.

The research found that compound 6, a newly created steroid, is more effective at inhibiting 5α-reductase (an enzyme) than current treatments, suggesting it could be a better option for treating urinary tract symptoms in men.

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

IL-17 inhibitors for psoriasis may cause unexpected hair loss.

CB-03-01 is a promising skin cream for treating hormone-related skin problems without causing harmful body-wide effects.

Blocking IL-17a can improve age-related smell loss in mice.

Higher IL-17A and IL-23 levels are linked to alopecia areata severity and could help in tracking and treating the disease.

Higher levels of IL-17A and IL-2 are linked to alopecia areata.

Targeting IL-17 could help treat pattern hair loss.

Higher IL-17A levels indicate more severe alopecia areata.

Cortexolone 17a-propionate may be an effective new treatment for hair loss.

Clofazimine may be effective for treating ashy dermatosis.

PRP treatment reduces inflammation and increases interleukin-10 in alopecia areata patients.

Keratin 17 is modified by RSK1 in response to growth and stress, affecting skin growth and stress response.